Browse

You are looking at 551 - 600 of 1,337 items for :

  • Clinical Resources x
  • Refine by Access: All content x
Clear All
Restricted access

Solution/Suspension/Syrup

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Sotalol Hydrochloride Suspension 5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

SECTION 2: Specific Drugs and Drug Classes

John E. Murphy

Restricted access

Spironolactone 5 mg/mL and Hydrochlorothiazide 5 mg/mL Suspension—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Spironolactone 5 mg/mL and Hydrochlorothiazide 5 mg/mL Suspension—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Spironolactone Suspension 2.5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Spironolactone Suspension 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Spironolactone Suspension 25 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Spironolactone Suspension 25 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Spironolactone Suspension 26 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Spironolactone Syrup 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Spironolactone Syrup 2.5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Spironolactone Syrup 5 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Sulfadiazine Suspension 100 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Sulfasalazine Suspension 100 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Sulfasalazine Suspension 100 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Sumatriptan Succinate Suspension 5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Sunitinib Malate Suspension 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

PART II SYSTEM DISORDERS AND DIAGNOSTIC TESTS

Christopher J. Edwards and Brian L. Erstad

Restricted access

Tacrolimus Monohydrate Suspension 0.5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Tacrolimus Monohydrate Suspension 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Tacrolimus Suspension 0.5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Tacrolimus Suspension 1 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Tadalafil Suspension 5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Temozolomide Suspension 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Terbinafine Hydrochloride Suspension 25 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Terbinafine Suspension 25 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Terbutaline Sulfate Syrup 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

PART III TESTS FOR SPECIAL POPULATIONS

Christopher J. Edwards and Brian L. Erstad

Restricted access

Tetracycline Hydrochloride Suspension 25 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Tetracycline Hydrochloride Suspension 25 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Thalidomide Suspension 20 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

20 THEOPHYLLINE

Catherine B. Hobart and Hanna Phan

Restricted access

Theophylline Suspension 5 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Theophylline Suspension 5 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Thiamine Suspension 100 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Thioguanine Suspension 20 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Tiagabine Hydrochloride Suspension 1 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Tiagabine Hydrochloride Suspension 1 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Tinidazole Syrup 66.7 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Tobramycin Sulfate Ophthalmic Solution 13.6 mg/mL (Fortified)

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Tobramycin Sulfate Ophthalmic Solution 15 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Topical/Ophthalmic Solution

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Topiramate Suspension 5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Tramadol Hydrochloride 7.5 mg/mL and Acetaminophen 65 mg/mL Suspension

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Tramadol Hydrochloride Suspension 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Tramadol Hydrochloride Suspension 5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Trimethoprim Suspension 10 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Trimethoprim Suspension 10 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

CH 1.8 Unfractionated Heparin and Low Molecular Weight Heparins

John E. Murphy